Pyxis Oncology Inc (PYXS)
0.9452 x 30 0.9880 x 1
Post-market by (Cboe BZX)
0.9854 +0.1081 (+12.32%) 04/09/25 [NASDAQ]
0.9452 x 30 0.9880 x 1
Post-market 0.9002 -0.0852 (-8.65%) 17:48 ET
for Wed, Apr 9th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PYXS | CPIX | MGX | ||
| Company | Pyxis Oncology Inc | Cumberland Pharmaceu | Metagenomi Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.8800 | 3.96 | 1.3600 | ||
| High | 1.0400 | 4.24 | 1.5494 | ||
| Low | 0.8625 | 3.86 | 1.3500 | ||
| Last | 0.9854 | 4.15 | 1.5000 | ||
| Change | +0.1081 | +0.24 | +0.1000 | ||
| % Change | +12.32% | +6.14% | +7.14% | ||
| Volume | 681,300 | 28,800 | 363,100 | ||
| 20-Day Average Volume | 507,090 | 49,915 | 451,665 | ||
| Previous Close | 0.8773 | 3.91 | 1.4000 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0466 | 4.55 | 1.5675 | ||
| 20-Day Raw Stochastic | 37.05% | 16.67% | 31.88% | ||
| 20-Day Relative Strength | 42.63% | 46.30% | 38.64% | ||
| Weighted Alpha | -67.48 | -21.05 | -86.08 | ||
| Today's Opinion | 100% Sell | 40% Buy | 100% Sell | ||
| Previous Opinion | 100% Sell | 40% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.39% since 04/02/25 | -3.04% since 04/02/25 | +12.78% since 04/02/25 | ||
| Low | 0.8332 on 04/07/25 | 3.86 on 04/09/25 | 1.2300 on 04/04/25 | ||
| High | 1.0400 on 04/09/25 | 4.36 on 04/03/25 | 1.5700 on 04/07/25 | ||
| 1-Month | |||||
| %Chg | -15.05% since 03/07/25 | -34.85% since 03/07/25 | -27.54% since 03/07/25 | ||
| Low | 0.8332 on 04/07/25 | 3.86 on 04/09/25 | 1.2300 on 04/04/25 | ||
| High | 1.2440 on 03/24/25 | 6.39 on 03/10/25 | 2.0950 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | -38.80% since 01/08/25 | +86.10% since 01/08/25 | -51.46% since 01/08/25 | ||
| Low | 0.8332 on 04/07/25 | 2.08 on 02/03/25 | 1.2300 on 04/04/25 | ||
| High | 1.6700 on 01/31/25 | 7.25 on 03/05/25 | 4.0000 on 01/22/25 | ||
| 6-Month | |||||
| %Chg | -68.72% since 10/09/24 | +226.77% since 10/09/24 | -23.08% since 10/09/24 | ||
| Low | 0.8332 on 04/07/25 | 1.04 on 11/25/24 | 1.2300 on 04/04/25 | ||
| High | 5.3899 on 11/11/24 | 7.25 on 03/05/25 | 4.9200 on 12/10/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 54,033 | 54,615 | 52,336 | ||
| Shares Outstanding, K | 61,590 | 13,968 | 37,383 | ||
| Annual Sales | 16,150,000 | 37,870,000 | 52,300,000 | ||
| Annual Net Income | -77,330,000 | -6,480,000 | -78,060,000 | ||
| Last Quarter Sales | 0 | 10,440,000 | 9,610,000 | ||
| Last Quarter Net Income | -35,570,000 | -1,900,000 | -23,400,000 | ||
| 60-Month Beta | 1.17 | -0.24 | -0.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/18/25 | -0.02 on 03/04/25 | -0.63 on 03/17/25 | ||
| Latest Earnings Date | 05/13/25 | 05/06/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||